Obstructive Sleep Apnea News and Research RSS Feed - Obstructive Sleep Apnea News and Research

Obstructive sleep apnea (OSA) is a major heath problem. In the United States, at least 17 million people have moderate to severe OSA, which is characterized by heavy snoring, airway blockage and frequent awakenings during sleep. OSA is one of the major causes of severe daytime sleepiness, and is a major risk factor for automobile accidents and workplace injuries. If left untreated, OSA has been implicated as a major risk factor for cardiovascular disease, including hypertension and heart failure, as well as stroke.

OSA is caused by collapse of the upper airway during sleep, and treatment for the disorder is based upon therapies that keep the airway open. The most common treatment for OSA is continuous positive airway pressure (CPAP). At least 50% of patients with OSA find it difficult or impossible to use CPAP and are therefore candidates for surgery. However, current surgical options for these patients are very limited, particularly related to the tongue base.
PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

A study of hospitalized cardiac patients is the first to show that effective treatment with positive airway pressure therapy reduces 30-day hospital readmission rates and emergency department visits in patients with both heart disease and sleep apnea. [More]
Consultant Live unveils new online sleep disorders educational program for doctors, nurses

Consultant Live unveils new online sleep disorders educational program for doctors, nurses

UBM Medica US announces that Consultant Live a leading online community for primary care clinicians, has unveiled a new online sleep disorders educational program to help doctors and nurses help their patients get a good night's rest. [More]
Closer monitoring needed to help prevent repeat strokes

Closer monitoring needed to help prevent repeat strokes

People who have had a stroke or transient ischemic attack (TIA or mini-stroke) are at high risk for a second similar event or other serious medical problems for at least five years and need better follow up and strategies to prevent these problems, according to data presented at the Canadian Stroke Congress. [More]
Tongue fat, size linked to obstructive sleep apnea in obese adults

Tongue fat, size linked to obstructive sleep apnea in obese adults

Obesity is a risk factor for many health problems, but a new Penn Medicine study published this month in the journal Sleep suggests having a larger tongue with increased levels of fat may be a sign of obstructive sleep apnea (OSA) in obese adults. [More]
Increasing prevalence of obstructive sleep apnea threatens public health and safety

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Public health and safety are threatened by the increasing prevalence of obstructive sleep apnea, which now afflicts at least 25 million adults in the U.S., according to the National Healthy Sleep Awareness Project. Several new studies highlight the destructive nature of obstructive sleep apnea, a chronic disease that increases the risk of high blood pressure, heart disease, Type 2 diabetes, stroke and depression. [More]
Screening and treating OSA patients prior to surgery reduce risk of cardiovascular complications

Screening and treating OSA patients prior to surgery reduce risk of cardiovascular complications

Scheduled for surgery? New research suggests that you may want to get screened and treated for obstructive sleep apnea (OSA) before going under the knife. According to a first-of-its-kind study in the October issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists-, patients with OSA who are diagnosed and treated for the condition prior to surgery are less likely to develop serious cardiovascular complications such as cardiac arrest or shock. [More]
Researchers find that people suffering from sleep apnea have weaker brain blood flow

Researchers find that people suffering from sleep apnea have weaker brain blood flow

Employing a measure rarely used in sleep apnea studies, researchers at the UCLA School of Nursing have uncovered evidence of what may be damaging the brain in people with the sleep disorder - weaker brain blood flow. [More]
One year of CPAP therapy restores white matter, improves cognition and mood

One year of CPAP therapy restores white matter, improves cognition and mood

A neuroimaging study is the first to show that white matter damage caused by severe obstructive sleep apnea can be reversed by continuous positive airway pressure therapy. [More]
Sleeping 7 to 8 hours per night associated with lowest risk of work absence

Sleeping 7 to 8 hours per night associated with lowest risk of work absence

New research suggests that sleeping 7 to 8 hours per night is associated with the lowest risk of absence from work due to sickness. [More]
UH Case Medical Center offers new FDA-approved treatment for obstructive sleep apnea

UH Case Medical Center offers new FDA-approved treatment for obstructive sleep apnea

University Hospitals Case Medical Center is the first in Ohio and among the first in the United States to begin offering a new FDA-approved treatment for obstructive sleep apnea (OSA). [More]
Severe obstructive sleep apnea associated with elevated blood pressure despite medication use

Severe obstructive sleep apnea associated with elevated blood pressure despite medication use

A new study shows a strong association between severe, untreated obstructive sleep apnea and the risk of elevated blood pressure despite the use of high blood pressure medications. [More]
Weight loss most important factor for improving cardiovascular health in obese OSA patients

Weight loss most important factor for improving cardiovascular health in obese OSA patients

Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with a variety of cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol, and high blood pressure. While effective therapies are available for OSA, researchers are still unclear about what interventions are most effective in reducing the burden of risk factors for cardiovascular disease associated with OSA in obese patients. [More]
USITC rules out patent claims on Apex's CPAP-complimentary mask

USITC rules out patent claims on Apex's CPAP-complimentary mask

Apex Medical Corporation a leading player in the Respiratory Therapy and Pressure Area Care sectors, announced that it has successfully obtained an initial advisory opinion from the United States International Trade Commission (USITC) that its continuous positive airway pressure (CPAP)-complimentary mask product is free from patent claims previously asserted by its Australia-based competitor, ResMed. [More]
Study demonstrates link between obstructive sleep apnea and development of diabetes

Study demonstrates link between obstructive sleep apnea and development of diabetes

In the largest study to date of the relationship between sleep apnea and diabetes, a new study of more than 8,500 Canadian patients has demonstrated a link between obstructive sleep apnea (OSA) and the development of diabetes, confirming earlier evidence of such a relationship from smaller studies with shorter follow-up periods. [More]
Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

1 in 2 hypertensive pregnant women who habitually snore may have unrecognized obstructive sleep apnea, a sleeping disorder that can reduce blood oxygen levels during the night and that has been linked to serious health conditions, new University of Michigan-led research shows. [More]
Compliance with CPAP therapy may help prevent cardiovascular complications

Compliance with CPAP therapy may help prevent cardiovascular complications

A new study suggests that continuous positive airway pressure (CPAP) therapy rapidly improves blood pressure and arterial tone in adults with obstructive sleep apnea (OSA). [More]
Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals plc today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a potential new treatment for the symptoms of excessive daytime sleepiness (EDS) in adults with narcolepsy. [More]
Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Actavis plc today announced that it has entered into an agreement with Cephalon, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Nuvigil® (armodafinil tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg). [More]
Study explores role of family factors in CPAP adherence in sleep apnea patients

Study explores role of family factors in CPAP adherence in sleep apnea patients

A new study suggests that people with obstructive sleep apnea (OSA) who are single or have unsupportive family relationships may be less likely to adhere to continuous positive airway pressure (CPAP) therapy. [More]
Home testing and CPAP therapy initiation for OSA may reduce costs without sacrificing clinical outcomes

Home testing and CPAP therapy initiation for OSA may reduce costs without sacrificing clinical outcomes

Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference. [More]